Human Relaxin Decreases Collagen Accumulation In Vivo in Two Rodent Models of Fibrosis
- 1 September 1993
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 101 (3) , 280-285
- https://doi.org/10.1111/1523-1747.ep12365206
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Recombinant Human Transforming Growth Factor—Beta 1 (rhTGF-β1) Enhances Healing and Strength of Granulation Skin WoundsGrowth Factors, 1990
- Platelet-derived growth factor and transforming growth factor-beta enhance tissue repair activities by unique mechanisms.The Journal of cell biology, 1989
- Transforming growth factor β (TGFβ) causes a persistent increase in steady-state amounts of type I and type III collagen and fibronectin mRNAs in normal human dermal fibroblastsBiochemical Journal, 1987
- Accelerated Healing of Incisional Wounds in Rats Induced by Transforming Growth Factor-βScience, 1987
- Transforming growth factor-beta increases steady state levels of type I procollagen and fibronectin messenger RNAs posttranscriptionally in cultured human dermal fibroblasts.Journal of Clinical Investigation, 1987
- Gamma-interferon inhibits collagen synthesis in vivo in the mouse.Journal of Clinical Investigation, 1987
- Transforming growth factor type beta: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro.Proceedings of the National Academy of Sciences, 1986
- The effect of oestrogen and relaxin on uterine and cervical enzymes: collagenase, proteoglycanase and β-glycuronidaseActa Endocrinologica, 1986
- Regulatory influence of relaxin on human cervical and uterine connective tissueActa Endocrinologica, 1984
- Utilization of the Relaxed Symphysis Pubis of Guinea Pigs for Clues to the Mechanism of OvulationEndocrinology, 1973